Keith W Marshall - Net Worth and Insider Trading
Keith W Marshall Net Worth
The estimated net worth of Keith W Marshall is at least $2 Million dollars as of 2024-12-27. Keith W Marshall is the CFO of Prometheus Biosciences Inc and owns about 9,811 shares of Prometheus Biosciences Inc (RXDX) stock worth over $2 Million. Details can be seen in Keith W Marshall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith W Marshall has not made any transactions after 2023-04-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith W Marshall
Keith W Marshall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith W Marshall owns 2 companies in total, including Histogen Inc (HSTOQ) , and Prometheus Biosciences Inc (RXDX) .
Click here to see the complete history of Keith W Marshall’s form 4 insider trades.
Insider Ownership Summary of Keith W Marshall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HSTOQ | Histogen Inc | 2020-05-22 | EVP & COO & CFO |
| RXDX | Prometheus Biosciences Inc | 2023-04-05 | Chief Financial Officer |
Keith W Marshall Latest Holdings Summary
Keith W Marshall currently owns a total of 1 stock. Keith W Marshall owns 9,811 shares of Prometheus Biosciences Inc (RXDX) as of April 5, 2023, with a value of $2 Million.
Latest Holdings of Keith W Marshall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXDX | Prometheus Biosciences Inc | 2023-04-05 | 9,811 | 199.92 | 1,961,415 |
Holding Weightings of Keith W Marshall
Keith W Marshall Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith W Marshall has made a total of 4 transactions in Prometheus Biosciences Inc (RXDX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Prometheus Biosciences Inc is the sale of 10,000 shares on April 5, 2023, which brought Keith W Marshall around $1 Million.
Insider Trading History of Keith W Marshall
- 1
Keith W Marshall Trading Performance
Keith W Marshall Ownership Network
Keith W Marshall Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Keith W Marshall is the EVP & COO & CFO of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTOQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Keith W Marshall Mailing Address
Above is the net worth, insider trading, and ownership report for Keith W Marshall. You might contact Keith W Marshall via mailing address: C/o Conatus Pharmaceuticals Inc., 16745 West Bernardo Drive, Suite 200, San Diego Ca 92127.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
